Neubie Treatment for Multiple Sclerosis

N/A

Waitlist Available

Led By Courtney Ellerbusch, DPT

Research Sponsored by CommonSpirit Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing the Neubie device, which uses electrical signals to help muscles and joints move more naturally. It targets people with multiple sclerosis who suffer from severe muscle stiffness. The goal is to see if this treatment can reduce stiffness and improve movement by resetting the body's muscle sensors.

Eligible Conditions

Multiple Sclerosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

12 item MS walking scale

Expanded Disability Status Score

Manual Muscle Test

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Neubie TreatmentExperimental Treatment1 Intervention

Participants in this study will participate in intervention treatment with the Neubie for 6 weeks. Outcome measures objective and subjective will be collected at the beginning and end of the study. The treatments will include: 1. Manual activations to underactive, spastic or limited in sensory muscles/regions 2. Neubie Mapping mode scanning process to scan for 1) spots that stimulate movement they couldn't do before per initial assessment, 2) spots that allow movement which is a greater range than available before per initial assessment, 3) spots that lead to decreased spasticity, and 4) diminished sensation areas - drive signal to increase sensory nerves and become metabolically active. 3. Train using physical therapy exercises with Neubie in training mode and Hz current adjusted for tolerance (perceived 7/10) and ability to work through or decrease spasticity in (500 Hz) in the areas which show spasticity, contraction, are dead/diminished sensation, and hot spots.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Neubie

2021

N/A

~10

Do I qualify?Apply below to find out